ChemBriefBioNexus Gene Lab Corp (BGLC) Grants CEO 338,709 Fully Vested Shares
BioNexus Gene Lab Corp awarded its CEO 338,709 fully vested common shares valued at $1.55 per share under the 2025 Equity Incentive Plan.
Stock Titan · 2026-08-14 21:43
1 articles
BioNexus Gene Lab Corp awarded its CEO 338,709 fully vested common shares valued at $1.55 per share under the 2025 Equity Incentive Plan.